Table 5 Odds of suffering the primary outcome in patients with G6PDd compared to non-G6PDd patients.

From: Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?

Type of analysis

OR (95% CI)

p value

Crude

0.69 (0.33, 1.45)

0.337

Adjusted for age, nationality, drug interventions, comorbidities (HTN, COPD, CKD, SCD)

0.403 (0.142, 1.148)

0.089

  1. HTN Hypertension, COPD Chronic Obstructive Pulmonary Disease, CKD Chronic Kidney Disease, SCD Sickle Cell Disease.
Back to article page